US Benchmarking Clinical Study
NCT07215715
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this observational study is to measure shear wave velocity (SWV) in patients with non-reduced left ventricular ejection fraction (LVEF) heart failure and left ventricular hypertrophy, with or without transthyretin amyloidosis with cardiomyopathy (ATTR-CM), and in control subjects without heart failure or cardiomyopathy. The main question it aims to answer is: • Can SWV be used to measure myocardial and liver stiffness in the study's target populations?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- HFpEF - Heart Failure With Preserved Ejection Fraction
- HFmrEF
- ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
- Left Ventricular Hypertrophy
- Cardiac Amyloidosis
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- eMyosound SAS
- Last updated on ClinicalTrials.gov
- October 20, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 3
- Boston Medical Center · Boston, MA
- Brigham and Women's Hospital · Boston, MA
- Massachusetts General Hospital · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.